Global HER2-negative Breast Cancer Market Professional Survey Report Forecast 2017 to 2022

November 2017 | 107 pages | ID: G126C1A0A9CEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

This report studies HER2-negative Breast Cancer in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2017, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
F. Hoffmann-La Roche
Novartis
Pfizer
AbbVie
AstraZeneca
BioMarin
Bristol-Myers Squibb
Eisai
Eli Lilly

By types, the market can be split into
Type 1
Type 2
Type 3

By Application, the market can be split into
Application 1
Application 2
Application 3

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

Contents

1 INDUSTRY OVERVIEW OF HER2-NEGATIVE BREAST CANCER

1.1 Definition and Specifications of HER2-negative Breast Cancer
  1.1.1 Definition of HER2-negative Breast Cancer
  1.1.2 Specifications of HER2-negative Breast Cancer
1.2 Classification of HER2-negative Breast Cancer
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Applications of HER2-negative Breast Cancer
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF HER2-NEGATIVE BREAST CANCER

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of HER2-negative Breast Cancer
2.3 Manufacturing Process Analysis of HER2-negative Breast Cancer
2.4 Industry Chain Structure of HER2-negative Breast Cancer

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF HER2-NEGATIVE BREAST CANCER

3.1 Capacity and Commercial Production Date of Global HER2-negative Breast Cancer Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global HER2-negative Breast Cancer Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global HER2-negative Breast Cancer Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global HER2-negative Breast Cancer Major Manufacturers in 2016

4 GLOBAL HER2-NEGATIVE BREAST CANCER OVERALL MARKET OVERVIEW

4.1 2012-2017 Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017 Global HER2-negative Breast Cancer Capacity and Growth Rate Analysis
  4.2.2 2016 HER2-negative Breast Cancer Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017 Global HER2-negative Breast Cancer Sales and Growth Rate Analysis
  4.3.2 2016 HER2-negative Breast Cancer Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017 Global HER2-negative Breast Cancer Sales Price
  4.4.2 2016 HER2-negative Breast Cancer Sales Price Analysis (Company Segment)

5 HER2-NEGATIVE BREAST CANCER REGIONAL MARKET ANALYSIS

5.1 North America HER2-negative Breast Cancer Market Analysis
  5.1.1 North America HER2-negative Breast Cancer Market Overview
  5.1.2 North America 2012-2017 HER2-negative Breast Cancer Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017 HER2-negative Breast Cancer Sales Price Analysis
  5.1.4 North America 2016 HER2-negative Breast Cancer Market Share Analysis
5.2 China HER2-negative Breast Cancer Market Analysis
  5.2.1 China HER2-negative Breast Cancer Market Overview
  5.2.2 China 2012-2017 HER2-negative Breast Cancer Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017 HER2-negative Breast Cancer Sales Price Analysis
  5.2.4 China 2016 HER2-negative Breast Cancer Market Share Analysis
5.3 Europe HER2-negative Breast Cancer Market Analysis
  5.3.1 Europe HER2-negative Breast Cancer Market Overview
  5.3.2 Europe 2012-2017 HER2-negative Breast Cancer Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017 HER2-negative Breast Cancer Sales Price Analysis
  5.3.4 Europe 2016 HER2-negative Breast Cancer Market Share Analysis
5.4 Southeast Asia HER2-negative Breast Cancer Market Analysis
  5.4.1 Southeast Asia HER2-negative Breast Cancer Market Overview
  5.4.2 Southeast Asia 2012-2017 HER2-negative Breast Cancer Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017 HER2-negative Breast Cancer Sales Price Analysis
  5.4.4 Southeast Asia 2016 HER2-negative Breast Cancer Market Share Analysis
5.5 Japan HER2-negative Breast Cancer Market Analysis
  5.5.1 Japan HER2-negative Breast Cancer Market Overview
  5.5.2 Japan 2012-2017 HER2-negative Breast Cancer Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017 HER2-negative Breast Cancer Sales Price Analysis
  5.5.4 Japan 2016 HER2-negative Breast Cancer Market Share Analysis
5.6 India HER2-negative Breast Cancer Market Analysis
  5.6.1 India HER2-negative Breast Cancer Market Overview
  5.6.2 India 2012-2017 HER2-negative Breast Cancer Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017 HER2-negative Breast Cancer Sales Price Analysis
  5.6.4 India 2016 HER2-negative Breast Cancer Market Share Analysis

6 GLOBAL 2012-2017 HER2-NEGATIVE BREAST CANCER SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017 HER2-negative Breast Cancer Sales by Type
6.2 Different Types of HER2-negative Breast Cancer Product Interview Price Analysis
6.3 Different Types of HER2-negative Breast Cancer Product Driving Factors Analysis
  6.3.1 General keyboard membrane of HER2-negative Breast Cancer Growth Driving Factor Analysis
  6.3.2 Transparent keyboard membrane of HER2-negative Breast Cancer Growth Driving Factor Analysis
  6.3.3 Simulation keyboard membrane of HER2-negative Breast Cancer Growth Driving Factor Analysis
  6.3.4 Colorful keyboard membrane of HER2-negative Breast Cancer Growth Driving Factor Analysis
  6.3.5 Other of HER2-negative Breast Cancer Growth Driving Factor Analysis

7 GLOBAL 2012-2017 HER2-NEGATIVE BREAST CANCER SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017 HER2-negative Breast Cancer Consumption by Application
7.2 Different Application of HER2-negative Breast Cancer Product Interview Price Analysis
7.3 Different Application of HER2-negative Breast Cancer Product Driving Factors Analysis
  7.3.1 Office Use of HER2-negative Breast Cancer Growth Driving Factor Analysis
  7.3.2 Personal Use of HER2-negative Breast Cancer Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF HER2-NEGATIVE BREAST CANCER

8.1 F. Hoffmann-La Roche
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Picture and Specifications
  8.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Novartis
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Picture and Specifications
  8.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Pfizer
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Picture and Specifications
  8.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 AbbVie
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Picture and Specifications
  8.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 AstraZeneca
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Picture and Specifications
  8.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 BioMarin
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Picture and Specifications
  8.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Bristol-Myers Squibb
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Picture and Specifications
  8.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Eisai
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Picture and Specifications
  8.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Eli Lilly
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Picture and Specifications
  8.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

9 DEVELOPMENT TREND OF ANALYSIS OF HER2-NEGATIVE BREAST CANCER MARKET

9.1 Global HER2-negative Breast Cancer Market Trend Analysis
  9.1.1 Global 2017-2022 HER2-negative Breast Cancer Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 HER2-negative Breast Cancer Sales Price Forecast
9.2 HER2-negative Breast Cancer Regional Market Trend
  9.2.1 North America 2017-2022 HER2-negative Breast Cancer Consumption Forecast
  9.2.2 China 2017-2022 HER2-negative Breast Cancer Consumption Forecast
  9.2.3 Europe 2017-2022 HER2-negative Breast Cancer Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 HER2-negative Breast Cancer Consumption Forecast
  9.2.5 Japan 2017-2022 HER2-negative Breast Cancer Consumption Forecast
  9.2.6 India 2017-2022 HER2-negative Breast Cancer Consumption Forecast
9.3 HER2-negative Breast Cancer Market Trend (Product Type)
9.4 HER2-negative Breast Cancer Market Trend (Application)

10 HER2-NEGATIVE BREAST CANCER MARKETING TYPE ANALYSIS

10.1 HER2-negative Breast Cancer Regional Marketing Type Analysis
10.2 HER2-negative Breast Cancer International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of HER2-negative Breast Cancer by Regions
10.4 HER2-negative Breast Cancer Supply Chain Analysis

11 CONSUMERS ANALYSIS OF HER2-NEGATIVE BREAST CANCER

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of HER2-negative Breast Cancer
Table Product Specifications of HER2-negative Breast Cancer
Table Classification of HER2-negative Breast Cancer
Figure Global Production Market Share of HER2-negative Breast Cancer by Type in 2016
Table Applications of HER2-negative Breast Cancer
Figure Global Consumption Volume Market Share of HER2-negative Breast Cancer by Application in 2016
Figure Market Share of HER2-negative Breast Cancer by Regions
Figure North America HER2-negative Breast Cancer Market Size (2012-2022)
Figure China HER2-negative Breast Cancer Market Size (2012-2022)
Figure Europe HER2-negative Breast Cancer Market Size (2012-2022)
Figure Southeast Asia HER2-negative Breast Cancer Market Size (2012-2022)
Figure Japan HER2-negative Breast Cancer Market Size (2012-2022)
Figure India HER2-negative Breast Cancer Market Size (2012-2022)
Table HER2-negative Breast Cancer Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of HER2-negative Breast Cancer in 2016
Figure Manufacturing Process Analysis of HER2-negative Breast Cancer
Figure Industry Chain Structure of HER2-negative Breast Cancer
Table Capacity and Commercial Production Date of Global HER2-negative Breast Cancer Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global HER2-negative Breast Cancer Major Manufacturers in 2016
Table R&D Status and Technology Source of Global HER2-negative Breast Cancer Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global HER2-negative Breast Cancer Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of HER2-negative Breast Cancer 2012-2017
Figure Global 2012-2017 HER2-negative Breast Cancer Market Size (Volume) and Growth Rate
Figure Global 2012-2017 HER2-negative Breast Cancer Market Size (Value) and Growth Rate
Table 2012-2017 Global HER2-negative Breast Cancer Capacity and Growth Rate
Table 2016 Global HER2-negative Breast Cancer Capacity List (Company Segment)
Table 2012-2017 Global HER2-negative Breast Cancer Sales and Growth Rate
Table 2016 Global HER2-negative Breast Cancer Sales List (Company Segment)
Table 2012-2017 Global HER2-negative Breast Cancer Sales Price
Table 2016 Global HER2-negative Breast Cancer Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of HER2-negative Breast Cancer 2012-2017
Figure North America 2012-2017 HER2-negative Breast Cancer Sales Price
Figure North America 2016 HER2-negative Breast Cancer Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of HER2-negative Breast Cancer 2012-2017
Figure China 2012-2017 HER2-negative Breast Cancer Sales Price
Figure China 2016 HER2-negative Breast Cancer Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of HER2-negative Breast Cancer 2012-2017
Figure Europe 2012-2017 HER2-negative Breast Cancer Sales Price
Figure Europe 2016 HER2-negative Breast Cancer Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of HER2-negative Breast Cancer 2012-2017
Figure Southeast Asia 2012-2017 HER2-negative Breast Cancer Sales Price
Figure Southeast Asia 2016 HER2-negative Breast Cancer Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of HER2-negative Breast Cancer 2012-2017
Figure Japan 2012-2017 HER2-negative Breast Cancer Sales Price
Figure Japan 2016 HER2-negative Breast Cancer Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of HER2-negative Breast Cancer 2012-2017
Figure India 2012-2017 HER2-negative Breast Cancer Sales Price
Figure India 2016 HER2-negative Breast Cancer Sales Market Share
Table Global 2012-2017 HER2-negative Breast Cancer Sales by Type
Table Different Types HER2-negative Breast Cancer Product Interview Price
Table Global 2012-2017 HER2-negative Breast Cancer Sales by Application
Table Different Application HER2-negative Breast Cancer Product Interview Price
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche HER2-negative Breast Cancer Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis HER2-negative Breast Cancer Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer HER2-negative Breast Cancer Global Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie HER2-negative Breast Cancer Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca HER2-negative Breast Cancer Global Market Share (2012-2017)
Table BioMarin Basic Information List
Table BioMarin HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Figure BioMarin HER2-negative Breast Cancer Global Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb HER2-negative Breast Cancer Global Market Share (2012-2017)
Table Eisai Basic Information List
Table Eisai HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eisai HER2-negative Breast Cancer Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly HER2-negative Breast Cancer Global Market Share (2012-2017)
Figure Global 2017-2022 HER2-negative Breast Cancer Market Size (Volume) and Growth Rate Forecast
Figure Global 2017-2022 HER2-negative Breast Cancer Market Size (Value) and Growth Rate Forecast
Figure Global 2017-2022 HER2-negative Breast Cancer Sales Price Forecast
Figure North America 2017-2022 HER2-negative Breast Cancer Consumption Volume and Growth Rate Forecast
Figure China 2017-2022 HER2-negative Breast Cancer Consumption Volume and Growth Rate Forecast
Figure Europe 2017-2022 HER2-negative Breast Cancer Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2017-2022 HER2-negative Breast Cancer Consumption Volume and Growth Rate Forecast
Figure Japan 2017-2022 HER2-negative Breast Cancer Consumption Volume and Growth Rate Forecast
Figure India 2017-2022 HER2-negative Breast Cancer Consumption Volume and Growth Rate Forecast
Table Global Sales Volume of HER2-negative Breast Cancer by Types 2017-2022
Table Global Consumption Volume of HER2-negative Breast Cancer by Applications 2017-2022
Table Traders or Distributors with Contact Information of HER2-negative Breast Cancer by Regions

COMPANIES MENTIONED

F. Hoffmann-La Roche
Novartis
Pfizer
AbbVie
AstraZeneca
BioMarin
Bristol-Myers Squibb
Eisai
Eli Lilly
Galena Biopharma
Incyte
Merck
Merck Serono
Merrimack
Nektar
Tesaro